Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre study

Creators: BALLEARI E.; ROSSI E.; CLAVIO M.; CONGIU A.; GOBBI, MARCO; GROSSO M.; SECONDO V.; SPRIANO M.; TIMITILLI S.; GHIO, RICCARDO

Others:: Balleari, E.; Rossi, E.; Clavio, M.; Congiu, A.; Gobbi, Marco; Grosso, M.; Secondo, V.; Spriano, M.; Timitilli, S.; Ghio, Riccardo

Additional details